Form 8-K - Current report:
SEC Accession No. 0001193125-25-159793
Filing Date
2025-07-16
Accepted
2025-07-16 14:14:14
Documents
16
Period of Report
2025-07-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917538d8k.htm   iXBRL 8-K 31757
2 EX-4.1 d917538dex41.htm EX-4.1 77066
3 EX-5.1 d917538dex51.htm EX-5.1 15107
4 EX-10.1 d917538dex101.htm EX-10.1 189654
8 GRAPHIC g917538g0716011829831.jpg GRAPHIC 2409
  Complete submission text file 0001193125-25-159793.txt   516403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rani-20250714.xsd EX-101.SCH 2878
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20250714_lab.xml EX-101.LAB 17979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20250714_pre.xml EX-101.PRE 11277
18 EXTRACTED XBRL INSTANCE DOCUMENT d917538d8k_htm.xml XML 3655
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 251126979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)